Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy

Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response in most cases presses the question of how general efficacy can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistanc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Res
Huvudupphovsmän: Wang, Xiaohong, Schoenhals, Jonathan E, Li, Ailin, Valdecanas, David R, Ye, Huiping, Zhang, Fenglin, Tang, Chad, Krishnan, Sunil, Allison, James, Sharma, Padmanee, Hwu, Patrick, Komaki, Ritsuko, Overwijk, Willem, Gomez, Daniel R., Chang, Joe Y., Hahn, Stephen M., Cortez, Maria Angelica, Welsh, James W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875182/
https://ncbi.nlm.nih.gov/pubmed/27821490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-3142
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk